Vice President, Head of Quality Control (QC) Greater Reading, United Kingdom Area

Join Us in Changing Lives

At OXB, our people are at the heart of everything we do. We’re on a mission to enable life-changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day: Responsible, Responsive, Resilient, and Respectful.

We’re currently recruiting for a UK Head of QC to lead our UK QC department. In this role, you will oversee the technical and operational aspects of quality control throughout our pipeline, ensuring the highest standards of quality for our viral vector products, playing a key part in advancing our mission and making a real difference.

Your responsibilities in this role would be to:

Lead, develop and evolve the UK QC organisation, building a high-performing team through effective leadership, talent management, succession planning and capability development.

Design and optimise the UK QC operating model and organisational structure to ensure the function is scalable, efficient and aligned to current and future business needs.

Provide strategic leadership for QC operations, ensuring the compliant and timely delivery of analytical development, release and stability testing across the product lifecycle.

Ensure a robust and inspection-ready QC framework, maintaining compliance with GMP, regulatory requirements and client expectations for viral vector products.

Direct analytical strategy and external testing partnerships, including method lifecycle management, specification setting and oversight of outsourced laboratory activities.

Drive business performance through regulatory leadership, cross-functional collaboration and financial stewardship, supporting successful product progression, inspection readiness, operational excellence and cost control.

We are looking for:

Advanced scientific qualification (PhD preferred) in a relevant discipline, or equivalent industry experience, coupled with significant leadership experience within biologics, viral vector or advanced therapy environments.

Strategic organisational and people leadership, with a proven track record of building high-performing teams, developing capability, driving engagement and designing effective operating structures.

Deep knowledge of GMP and global regulatory requirements, including inspection readiness, analytical compliance, method validation, technology transfer and data integrity.

Strong analytical and technical leadership, with expertise in QC strategy, specification setting, analytical lifecycle management and resolution of complex quality challenges.

Commercial and operational acumen, including resource planning, budget accountability, workload prioritisation and management of outsourced testing partners.

Exceptional stakeholder management and communication skills, with the ability to influence and collaborate effectively across executive leadership, clients, regulators and cross-functional teams.

About Us:

OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world.

One of the original pioneers in cell and gene therapy, OXB has 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. OXB’s world-class capabilities range from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

OXB offers a vast number of technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the TetraVecta™ system), a dual-plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines.

OXB, a FTSE250 and FTSE4Good constituent, is headquartered in Oxford, UK. It has development and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France, Bedford MA, and Durham NC, US.

Why Join Us?

💸 Competitive total reward packages

🧘 Wellbeing programs that support your mental and physical health

🚀 Career development opportunities to help you grow and thrive

🤝 Supportive, inclusive, and collaborative culture

🧪 State-of-the-art labs and manufacturing facilities

🌍 A company that lives its values: Responsible, Responsive, Resilient, Respect

We want you to feel inspired every day. At OXB, we’re future-focused and growing fast. We succeed together—through passion, commitment, and teamwork.

Ready to Make a Difference?

The closing date for applications is Tuesday 17th November 2026

Please note: Our vacancies are typically advertised for a minimum of 10 working days. Once a vacancy closes, it may take a few days for us to provide an update while our Talent Acquisition team and Hiring managers review all applications.

Every application is reviewed manually by our recruitment team and hiring managers. We do not use AI to screen CVs or make shortlisting decisions.